Preparation of documents

25 November 2019

ClinPharmDevelopment begins developing a package of documents for conducting a phase 1 clinical trial of a domestic drug with fibrinolytic effect in patients with acute myocardial infarction.

Back to the list

The first bioanalogue of the original drug for the treatment of osteoporosis in Russia has received a registration certificate from the Ministry of Health.

A phase I study of an innovative drug used in the treatment of patients with a new coronavirus infection (COVID-19) has been completed. The final report has been prepared.

Subscribe to the newsletter of interesting articles and news

Prepa­ra­tion of documents

Preparation of documents